KR20160007744A - Composition for anti-hangover and anti-obesity containing extract of Mytilus edulis - Google Patents
Composition for anti-hangover and anti-obesity containing extract of Mytilus edulis Download PDFInfo
- Publication number
- KR20160007744A KR20160007744A KR1020140079059A KR20140079059A KR20160007744A KR 20160007744 A KR20160007744 A KR 20160007744A KR 1020140079059 A KR1020140079059 A KR 1020140079059A KR 20140079059 A KR20140079059 A KR 20140079059A KR 20160007744 A KR20160007744 A KR 20160007744A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- mussel
- hangover
- mytilus edulis
- composition
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/40—Shell-fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
The present invention relates to a hangover resolution and an anti-obesity functional composition comprising a mushroom extract as an active ingredient.
Mussel, Mytilus , which belongs to the mussel family, edulis ) is a Korean wave. It secures a sticky substance to dozens of beards called 足 糸 on rocks between 20m depths in the intertidal zone and fixes on the seashore, Eat the nutrients. The inside of the shell is called "Pearl mussel" because it is said to be pearly light, and it is also called "Marsh mussel" or "Mediterranean mussel" by the Mediterranean.
In general, mussels are known to be good for relieving hangovers, but the effect of mussels on alcohololysis enzymes has not been actually disclosed. Korean Patent No. 10-1122586 discloses a hangover-eliminating beverage containing abalone freeze-dried meat, and a food composition for improving and preventing liver disease containing shellfish extract is disclosed in Korean Patent Registration No. 10-0841476, Korean Patent Laid-Open No. 10-2009-0007676 discloses a health food for hangover seafood using or added with soybean sprouts, sweet potatoes, glutinous rice, barley, and plum extract. The hangover resolution activity of the mussel of the present invention is not implied or disclosed anywhere in the known literature.
It is therefore an object of the present invention to provide a hangover resolution functional composition comprising a mushroom extract.
Another object of the present invention is to provide a composition for preventing and treating obesity, which comprises a mushroom extract.
The above object of the present invention can be achieved by a method for producing a mussels extract of the present invention; Testing the antioxidant activity, ACE inhibitory activity, ADH and ALDH activity of the pearl mussel extract obtained in the above step; Analyzing the alcohol degrading ability and antioxidant enzyme of an animal liver tissue ingested with the mushroom extract of the present invention; And comparing and evaluating the activity of inhibiting adipocyte differentiation of pearl mussel extract.
INDUSTRIAL APPLICABILITY The present invention has an effect of providing a novel hangover safe health supplement, and at the same time, it has an excellent effect of being able to supply a composition excellent in prevention and treatment of obesity.
1 is a graph showing DPPH radical scavenging activity of a manganese hot water extract (BMF: mussel, BMW: p. Mussel).
2 is a graph showing an ACE (Angiotensin converting enzyme) inhibitory activity of the manganese hot-water extract.
FIG. 3 is a graph showing the effect of pearl mussel hot-water extract on ALDH (A) and ADH (B) activity.
Fig. 4 is a graph showing the activity of liver tissue alcoholase in experimental animals ingested with rhizome. Fig. NC: Negative control, A: Alcohol intake, A-BM: Alcohol + 5% boiled mussels, A-MS: Alcohol + 1% mussels.
FIG. 5 is a graph showing the activities of hepatic antioxidant enzymes catalase (A) and GSH-Px (B) in an experimental animal ingested with rhizome.
FIG. 6 is a graph showing DNA damage of hepatic tissue cells of an experimental animal ingesting a rhizome.
FIG. 7 is a graph showing cytotoxicity of 3T3-L1 cells of pearl moxibustion extract. FIG.
FIG. 8 is a flow chart showing the treatment period of pearl-marijuana extract and 3T3-L1 adipocyte differentiation.
Fig. 9 is a graph showing the activity of inhibiting adipocyte differentiation of pearl-marijuana extract.
Fig. 10 is a photograph showing changes in the number and size of lipid sphere according to the treatment of pearl-marijuana extract.
FIG. 11 is a flowchart showing a treatment period of pearl-marijuana extract and 3T3-L1 adipocyte differentiation.
FIG. 12 is a graph showing the effect of the treatment of the mulberry juice extract on adipocyte differentiation.
Fig. 13 is a photograph showing the effect of pearl mugwort water extract treatment on the number and size of lipid sphere.
14 is a graph showing a mechanism of inhibiting adipocyte differentiation of pearl moxibustion extract.
The present invention provides a hangover decomposing composition comprising 1 to 10% by weight of a mussel-free mussel or mussel extract of pearl mussel.
The present invention provides a pharmaceutical composition containing the above-described hangover remedy composition as an active ingredient and having a hangover resolution effect due to drinking.
The present invention provides a health supplement containing the above-described hangover remedy composition as an active ingredient and having a hangover resolution effect due to drinking.
The spoilage composition of the present invention comprises 1 to 10% by weight, preferably 5% by weight, of a mussel-free mussel or mussel extract.
The pharmaceutical composition of the present invention can be prepared into a conventional pharmaceutical formulation by selecting one or two or more pharmaceutically acceptable conventional carriers and one or more additives to the effective amount of the hangover decomposing composition as a main component .
The carrier may be selected from one or more selected from among diluents, lubricants, binders, disintegrants, sweeteners, stabilizers and preservatives. Examples of the additives include one or more of flavorings, vitamins and antioxidants The pharmaceutically acceptable composition of the present invention may be formulated into tablets, pills, tablets, capsules, soft capsules, solutions, powders, granules and the like and then taken orally.
In the present invention, any of the pharmaceutically acceptable carriers and additives may be used. Specific examples of the diluent include lactose monohydrate, cornstarch, soybean oil, microcrystalline cellulose, Magnesium stearate or talc is preferable as a lubricant and polyvinypyrrolidone (PVP) or hydroxypropylcellulose (HPC) is used as a binder. Is preferable. The disintegrant may be selected from carboxymethylcellulose calcium (Ca-CMC), sodium starch glycolate, polacrylin potassium or cross-linked polyvinylpyrrolidone And the sweetener is selected from the group consisting of white sugar, fructose, sorbitol or aspartame. Examples of the stabilizer include sodium carboxymethylcellulose sodium (Na-CMC), beta-cryclodextrin, White bee's wax or xanthan gum and preservatives include methyl p-hyroxy benzoate, methylparaben, propyl p-hyroxy benzoate, propylparaben or potassium sorbate (potassium sorbate).
The health supplement food containing the composition for hangover of the present invention can be used as a formulation for folk remedies such as tea, jelly, juice, juice, The health supplements of the invention are excellent in detoxification action without adverse effects on the human body, and are easy to take, which can be useful for relieving hangover before and after drinking.
Hereinafter, the present invention will be described in detail with reference to examples.
<Pearl mussel extract in vitro Hangover elimination test>
Disclosure material
We received the fresh juice from the Masan Fisheries Cooperative in May 2013. L-histidine-L-leucine (HHL), captopril, alcohol dehydrogenase (ADH), acetaldehyde dehydrogenase (ALDH) ascorbic acid, and NAD + were purchased from Sigma Chemical Co. (St. Louis, Mo., USA), and Hepos was purchased from commercial pharmacy.
Example : Manufacture of Pearl Mushroom Extract According to the Invention
The tap water was removed from the shell of the pearl mussels and the mussels were divided into a mussel and a mussel with only the edible part (meat) removed from the skin. Three times more purified water was added based on the weight of whole mussel (skin, meat) and extracted at 100 ℃ for 30 minutes. 1.00 kg of mussel was obtained from whole mussel 3.75 kg. Thus, hot water extract was prepared by adding purified water based on the weight of whole mussel using this ratio. Then, the extract was filtered with Whatman No.3 filter paper and lyophilized. The dried powder was diluted to 10, 20 and 30 mg / mL with distilled water and used as a test material in the experiment.
Experimental Example 1: Antioxidant activity of the extract of the mushroom of the present invention
The DPPH radical scavenging activity was measured by using the method of Jeong et al., And 0.9 mL of 0.041 mM DPPH solution was added to 0.1 mL of the sample, followed by reaction at room temperature for 30 minutes, and the absorbance was measured at 517 nm. The DPPH radical scavenging activity of each sample was calculated by the following formula and expressed as a percentage.
1, DPPH radical scavenging activity of blue mussel flesh (BMF) and whole blue mussel (BMW) hydrothermal extract was 36.81% and 30.81% at 10 mg / mL of pear mussels, respectively Respectively. The mussel extract showed higher antioxidant activity than the mussel hydrothermal extract and increased in concentration dependent manner.
Experimental Example 2: Invention of pearl mussel extract of the present invention ACE Inhibitory activity
ACE inhibitory activity was measured according to the method of Cushman and Cheung. To the 20 mL of 50 mM sodium borate buffer (pH 8.3), 1 g of rabbit lung acetone powder was stirred at 4 ° C for 24 hours and then centrifuged for 10 minutes at 4 ° C and 5,000 × g to obtain an ACE enzyme solution. 50 μL of each diluted sample was added, and preliminary reaction was carried out at 37 ° C. for 10 minutes. Then, 100 μL of 25 mM HHL was added thereto and reacted at 37 ° C. for 60 minutes. The reaction was stopped by adding 250 μL of 1 M HCl. The reaction was stopped by adding 1.5 mL of ethyl acetate, stirring for 30 seconds, and centrifugation (5,000 × g, 10 minutes, 4 ° C.) to obtain 1 mL of supernatant. The supernatant was completely dried at 80 ° C for 30 minutes, and 1 ml of distilled water was added thereto, and the absorbance was measured at 228 nm. As a control, 50 μL of extraction solvent was used and the ACE inhibitory activity was calculated using the following equation.
As shown in FIG. 2, the mussel and mussel extracts of the mussel and mussel showed 50.27% and 28.99% inhibitory activity at 30 mg / mL, respectively. As the concentration increased, ACE inhibitory activity also increased. The mussel extract showed higher ACE inhibitory activity than the mussel extract.
Experimental Example 3: Invention of Pearl mussel extract of the present invention ADH ( alcohol dehydrogenase ) activation
The effects of pearl mussel extract on ADH activity were measured by Bergmeyer 's method. The reaction solution was prepared by adding 1.4 mL of distilled water, 0.75 mL of 1.0 M Tris-HCl buffer (pH 8.8), 0.3 mL of 20 mM NAD +, 0.3 mL of 0.2 M ethanol, and 0.1 mL of the sample, followed by reaction at 25 ° C in a constant temperature water bath for 10 minutes Add 0.15 mL of ADH (5 units / mL) to adjust the reaction solution to 3 mL, and preliminarily react at 25 ° C for 5 minutes. Absorbance of the resultant NADH was measured at 340 nm for 5 minutes using a spectrophotometer. The relative activities of the compounds were compared. The negative control was the addition of distilled water instead of the sample, and the positive control was Hepos. The ADH activity was expressed as the ratio of the maximum absorbance at the end of the reaction to the maximum absorbance of the control, and was calculated by the following equation.
The reaction mixture consisted of 0.1 mL of distilled water, 0.3 mL of 1.0 M Tris-HCl buffer (pH 8.0), 0.1 mL of 20 mM NAD +, 0.1 mL of 0.1 M acetaldehyde, 0.1 mL of 3.0 M KCl, 0.1 mL of 0.33 M 2-mercaptoethanol, mL, and reacted at 25 ° C for 10 minutes. After adding 0.1 mL of ALDH (1 unit / mL), the reaction solution was adjusted to 3 mL, placed in a cuvette, preliminarily reacted at 25 ° C for 5 minutes, Formation was measured by a change in absorbance at 340 nm. Negative control and positive control activities were calculated using the same method as ADH activity measurement.
As shown in FIG. 3, ADH activity was increased in a concentration-dependent manner in the manganese hydrothermal extract and 220.25% and 219.10% at 30 mg / mL of mussel and mussel extracts, respectively. ALDH activity also increased in a concentration dependent manner. At 30 mg / mL concentration, mussel and mussel hot water extracts induced 142.96% and 162.10%, respectively.
Statistical analysis
All experiments were repeated 3 times or more, and the mean values were processed according to the method of General Linear Model using SPSS software (Ver. 12). One-way ANOVA was performed to determine the significance of the difference between the mean and the mean ± standard deviation. Differences in all treatment values were analyzed by comparing 95% confidence level (p <0.05).
<Pearl mussel extract in vivo Hangover elimination test>
Disclosure material
The samples used for the diet were 11.25 liters of water and 1 hour of heating at 100 ° C for 30 minutes to 1 kg of live pear mussels. After solely freezing the solids except for the shell, 5% of the amount was added to the diet, The pearl mackerel was prepared by adding 30 L of water to 10 kg of shell mussel, heating it at 100 ° C for 30 minutes, filtering it with Whatman no. 3, and lyophilizing it to add 1% to the diet.
Experimental animal
Five weeks old Wistar rats were allowed to adapt to the laboratory environment for one week, and then divided into four groups according to the nude method. Each group was divided into two groups: an isocaloric dextrin (NC), an alcohol-treated group (A), an alcohol + 5% pearl mushroom solid-treated group (A-BM) and an alcohol + 1% pearl mine-fed group (A-MS). The diets were mixed with mushroom solid and broth powder according to AIN-93. In the alcohol-treated group, 6 g / kg / day of alcohol was mixed with drinking water. All feeds were kept at 4 ° C and fed for 6 weeks. The animals were sacrificed after fasting for 12 hours, and blood and liver were collected and used for analysis. The dietary composition intake for 6 weeks is shown in [Table 2].
Experimental Example 4: Change of Animal by Pearl Mushroom Extract According to the Invention
The effects of pearl mussel solids and broth on body weight gain, dietary intake, and dietary efficiency after 6 weeks of alcohol consumption and diet supplemented with pearl mussel solids and broth were investigated. In all groups, weight gain, dietary intake, There was no significant difference between the two groups.
Table 6 shows the changes in long-term weights after ingestion of 6-week alcoholic beverages and dietary supplementation of pearl mussel solids and broth. As a result, there was no significant difference between groups in all organs.
Experimental Example 5: Pearl mussel extract in vivo Alcohololytic activity
The liver was mixed with 0.25M sucrose and homogenized at 4 ° C using a homogenizer. Then, the cytosol portion of the liver was separated from the supernatant by centrifugation at 600g for 10 minutes and then at 10,000g for 20 minutes. Subsequently, 0.1 mL of the supernatant was mixed with 0.2 mL of ethanol, 0.02 mL of 0.5 M semicarbazide, and 2.0 mL of preincubated reaction solution containing 0.1 M NAD and reacted at 37 ° C to measure absorbance at 340 nm. The activity was expressed in nmoles of NADH produced by 1 mg of protein.
As shown in FIG. 4, the ADH of the liver was the highest in group A, and that of the two groups in which the mussel solid and mussel broth were fed Similar to NC, ADH was decreased.
Experimental Example 6: Pearl mussel extract in vivo Antioxidant activity
A. Catalase Enzyme Activity: Liver tissues were homogenized using a homogenizer, centrifuged at 600 g for 10 min, centrifuged at 1000 g for 20 min, centrifuged at 1000 g for 20 min, treated with 1 × RBC Washed and used in the experiment. For the experiment, 0.05 mL of pellet and 0.3 mL of 30 mM hydrogen peroxide were added to 0.6 mL of 50 mM Na-K phosphate buffer (pH 7), and the decrease in hydrogen peroxide was measured at 240 nm for 30 seconds. Activity was expressed in nmoles of hydrogen peroxide per hour in 1 mg of protein.
B. GSH-Px (glutathione peroxidase) enzyme activity: The liver tissue was homogenized using a homogenizer (IKA® T10 basic, IKA Laboratory Equipment, Staufen, Germany) and centrifuged at 10,000 g for 20 min. Respectively. To 0.605 mL of sample solution (0.15 mL of 250 mM KP buffer (pH 7), 0.075 mL of 10 mM EDTA, 0.075 mL of 10 mM NaN, 0.075 mL of 10 mM GSH, 0.075 mL of 2 mM NADPH, 0.15 mL of DW, and 0.00501 mL) 0.025 mL was added, and the mixture was allowed to stand at room temperature for 5 minutes. After 5 minutes, 0.025 mL of 2.5 mM H 2
As shown in FIG. 5, the antioxidant enzyme activities in the liver tissues were significantly increased after ingesting the diets supplemented with the pearl mussel solids and the pearl mussels in the catalase than in the alcohol groups. However, GSH-Px, which plays a role in converting H 2 O 2 to H 2 O in liver tissues, was more active than the alcohol group in the group fed the pearl-soaked solid and the pearl-marinated meats.
Experimental Example 7: Expression of Hepatocyte Cells by Pearl Mushroom Extract DNA Damage degree
0.5 g of liver tissue was extracted and treated with 300 units of collagenase in HBSS buffer, followed by treatment at 37 ° C for 30 minutes. After centrifugation at 40 g for 5 minutes, the supernatant was separated and centrifuged at 700 g for 10 minutes to separate the cell lysate. The cell lysate was separated from the supernatant by a fully frosted slide precoated with 1% normal melting agarose (NMA) And LMA were dispersed evenly and then covered with cover glass and stored in a refrigerator at 4 ° C.
When the gel stiffened for electrophoresis, one double layer of LMA was loosened and DNA double strand was loosened during 1 hour immersion in cold Lysis solution. The slides are then placed in an electrophoresis bath, unwound in electrophoresis buffer for 20 minutes, and electrophoresed at 25 V / 300 mA for 20 minutes. After electrophoresis, the cells were washed thoroughly with Tris buffer, stained with ethidium bromide (20 μL / mL), observed with a fluorescence microscope, and analyzed by computer.
As shown in Figure 6, DNA damage is the% Tail DNA of all alcohol groups with significantly be treated as not treated with H 2 O 2 200μM H 2 O 2 was high. In addition, DNA damage of hepatic tissues was significantly lower than that of alcohol group, as% Tail DNA of pearl mussel solid and broth group was significantly lower than NC level.
Statistical analysis
The mean ± standard deviation (SE) was calculated according to each item, and the significance difference between the two groups was verified using Tukey's multiple range test.
<Test for suppressing obesity of pearl mussel extract>
Disclosure material
Fetal bovine serum (FBS) and Fetal calf serum (FCS) were purchased from Gibco BRL. Dulbecco's modified Eagle's medium (DMEM) and penicillin-streptomycin cocktail were purchased from WELGENE Inc. in Carlsbad, CA, USA. (Daegu, Korea). TRIzol® and SuperScriptII kit were purchased from Oil Red O, 3- (4,5-dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTT), U0126, SP600125, LY294002, SB431542, The thermal cycler for the polymerase chain reaction (PCR) was a Bio-Rad (Tokyo, Japan) microplate reader (Molecular Devices, Sunnyvale, CA, USA) and the IWR-1 was purchased from Sigma Japan) were used.
Experimental Example 8: Cytotoxicity of the extract of the mussel of the present invention
3T3-L1 preadipocytes were pre-cultured in 12-well culture plates and cultured in 3T3-L1 pre-adipocytes with 10, 50, 100, 200, 400, 600 and 800 μg / And treated with 0.2 mg / mL of MTT solution for 1 hour. The DMEM medium was then removed and the treated 3T3-L1 preadipocytes were washed with 1 mL of phosphate buffered saline (PBS, pH 7.4). MTT formazan, which is not soluble in aqueous solution, was dissolved in 400 μL of dimethyl sulfoxide (DMSO), and the absorbance was measured at 595 nm using a microplate reader.
As shown in FIG. 7, significant cell death was observed at a concentration of 600 and 800 μg / mL compared to the control (control) without any treatment, but concentrations of 10, 50, 100, 200 and 400 μg / mL The extract of pearl mackerel was not toxic to 3T3-L1 preadipocytes. In order to exclude the effect on cytotoxicity in the future, the pearl mushroom extract of 400 μg / mL or less was selectively used.
Experimental Example 9: Inhibition activity of adipocyte differentiation of pearl mackerel juice extract of the present invention
Mouse-derived 3T3-L1 cells were purchased from the American Type Culture Collection (ATCC; Rockville, Md., USA). 3T3-L1 preadipocytes were cultured in DMEM medium containing 10% FCS and 100 unit / mL of penicillin-streptomycin at 37 ° C and 5% CO 2 . To differentiate 3T3-L1 preadipocytes into adipocytes, the adipocytes were replaced with differentiation induction medium two days after becoming confluent, and the day of substitution with differentiation medium (DM) was designated as
As shown in Fig. 9, the pearl marijuana extract significantly inhibited adipocyte differentiation of 3T3-L1 cells in a concentration-dependent manner. The inhibition of adipocyte differentiation by 22.61%, 44.42% and 84.20%, respectively, compared with the differentiation rate (100%) of the untreated adipocytes in the 3T3-L1 cells treated with 100, 200 and 400 μg / .
Experimental Example 10: by pearl mackerel juice extract Local district change
The number and size of lipid droplets in differentiated 3T3-L1 adipocytes were qualitatively analyzed by microscopic observation. In the same manner as above, 3T3-L1 preadipocytes were treated with 100, 200, and 400 μg / mL of pearl marijuana extracts from Day -2 to
As shown in Fig. 9, the pear mussels extract decreased the size and number of fat spheres in a concentration-dependent manner compared with 3T3-L1 adipose cells that were not treated with anything.
Experimental Example 11: Inhibitory activity of adipocyte differentiation according to differentiation time
In order to investigate the mechanism of inhibition of adipocyte differentiation by 3T3-L1 cells, the adipocyte differentiation period (pre-A differentiation, early stage of B adipocyte differentiation, mid-C adipocyte differentiation stage, The mugwort extract was treated at concentrations of 100, 200 and 400 μg / mL. Adipocyte differentiation of 3T3-L1 cells was carried out in the same manner as described above and ended on Day 7 (Fig. 10).
Experimental results showed that the treatment of pearl-marijuana extract before induction of differentiation did not significantly affect adipocyte differentiation of 3T3-L1 cells. In addition, the extract of pearl mackerel showed inhibitory activity in early, middle and late stages of differentiation of adipocytes. Especially, in the early and middle stage of adipocyte differentiation, (Figs. 11 and 12).
Experimental Example 12: According to the present invention, Anti-obesity Mechanism
On
As shown in Fig. 13, the specific inhibitor used in this experiment is as follows. U0126 (ERK signaling system inhibitor), SP600125 (JNK signaling system inhibitor), LY294002 (PI3K signaling system inhibitor), SB431542 (TGF-β signaling system inhibitor), IWR-1 inhibitor). As a result of treatment with 100 and 400 μg / mL of mulberry juice extract, 25.61% and 84.20% of adipocyte differentiation was observed, respectively. The result of the simultaneous treatment of 400 μg / mL of pear mussels and U0126 (10 μM), SP600125 (5 μM), LY294002 (5 μM) and SB431542 (5 μM) specific signaling system specific inhibitors, The inhibitory activity of inhibition of differentiation was 84.20%, 81.14%, 88.99% and 94.59%, respectively, but no significant difference was observed. In contrast, the inhibition rate of 3T3-L1 cells in adipocyte differentiation was 63.63%, compared with 400 μg / mL of pearl-marijuana extract and IWR-1 (10 μM) The inhibitory activity of about 21% was decreased.
Statistical analysis
All data were expressed as mean ± SD. Data were analyzed statistically using Statistical Package for Social Science (SPSS, Chicago, IL, USA). The significance of the mean values was verified at the confidence level p <.05. Each item was subjected to one-way ANOVA and Duncan's test and t-test were used to verify the significance of each interval. p <.05, and significance was expressed as * or # <. 05, ** or ## <.01, and *** or ### <.001.
Claims (8)
Filtering the hot water extract obtained in the above step to separate the supernatant;
Lyophilizing the supernatant obtained in the above step; And
Wherein the dried pearl mite dry powder obtained in the above step is diluted with a carrier or an additive acceptable for food processing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140079059A KR20160007744A (en) | 2014-06-26 | 2014-06-26 | Composition for anti-hangover and anti-obesity containing extract of Mytilus edulis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140079059A KR20160007744A (en) | 2014-06-26 | 2014-06-26 | Composition for anti-hangover and anti-obesity containing extract of Mytilus edulis |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20160007744A true KR20160007744A (en) | 2016-01-21 |
Family
ID=55308320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140079059A KR20160007744A (en) | 2014-06-26 | 2014-06-26 | Composition for anti-hangover and anti-obesity containing extract of Mytilus edulis |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20160007744A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109043114A (en) * | 2018-06-22 | 2018-12-21 | 湖北瑞邦生物科技有限公司 | A kind of preparation process and its application of mussel extract |
CN113317462A (en) * | 2021-06-09 | 2021-08-31 | 沈阳农业大学 | Application of ethanol extract of common mussel in preparation of functional food for regulating oxidative stress injury of liver cells |
-
2014
- 2014-06-26 KR KR1020140079059A patent/KR20160007744A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109043114A (en) * | 2018-06-22 | 2018-12-21 | 湖北瑞邦生物科技有限公司 | A kind of preparation process and its application of mussel extract |
CN113317462A (en) * | 2021-06-09 | 2021-08-31 | 沈阳农业大学 | Application of ethanol extract of common mussel in preparation of functional food for regulating oxidative stress injury of liver cells |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4738464B2 (en) | Adiponectin secretion promoting food and drink | |
He et al. | Nutritional and medicinal characteristics of Chinese giant salamander (Andrias davidianus) for applications in healthcare industry by artificial cultivation: a review | |
US10980842B2 (en) | Composition for promotng bone formation with fermented oysters and seaweed | |
CN110023487B (en) | Novel lactobacillus sake and composition comprising same | |
Guardiola et al. | Quality and antioxidant response of gilthead seabream (Sparus aurata L.) to dietary supplements of fenugreek (Trigonella foenum graecum) alone or combined with probiotic strains | |
EP2271367B1 (en) | Mineral absorption accelerator and iron deficiency anemia improver or food composition | |
Yan et al. | Effect of fermented bee pollen on metabolic syndrome in high-fat diet-induced mice | |
US20210268047A1 (en) | Microbiological process for the production of bee bread | |
JP2010030917A (en) | Hepatitis-related preventive or therapeutic agent | |
KR20160007744A (en) | Composition for anti-hangover and anti-obesity containing extract of Mytilus edulis | |
JP5171080B2 (en) | Composition having antioxidative action | |
Sarumathi et al. | The protective efficacy of spirulina against bacterial endotoxin potentiated alcoholic liver disease | |
WO2014171333A1 (en) | Mitochondria activator | |
JP2010254594A (en) | Agent for promoting proliferation of bacteroides in intestine | |
JP2009137920A (en) | Glycogen phosphorylase inhibitor | |
JP7479521B2 (en) | NOVEL FECALIBACTERIUM PRAUSNITZII EB-FPDK9 STRAIN AND ITS USE | |
KR101672098B1 (en) | Composition for removing hangover comprising fermented rice rinse water | |
WO2015022978A1 (en) | Fat accumulation inhibitor, drug, prophylactic or therapeutic agent for fatty liver, food or drink, and method for producing fat accumulation inhibitor | |
JP5414316B2 (en) | Liver disorder inhibitor | |
Wu et al. | Safety evaluation and effects of dietary phlorotannins on the growth, health, and intestinal microbiota of Litopenaeus vannamei | |
JP2009084191A (en) | Pharmaceutical composition for inhibiting appetite | |
JP2021529183A (en) | Composition for diabetes improvement or antioxidant containing yeast extract and method for producing yeast extract | |
KR101734909B1 (en) | Novel use of Limonium tetragonum | |
JP2010006748A (en) | Dipeptidyl peptidase iv inhibitor | |
JP5264106B2 (en) | Composition having antioxidative action |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
E601 | Decision to refuse application | ||
E801 | Decision on dismissal of amendment | ||
J201 | Request for trial against refusal decision | ||
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2016101004747; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20160812 Effective date: 20180723 |